1
|
Ong HS and Corbett MC: Corneal infections
in the 21st century. Postgrad Med J. 91:565–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Taube MA, del Mar Cendra M, Elsahn A,
Christodoulides M and Hossain P: Pattern recognition receptors in
microbial keratitis. Eye (Lond). 29:1399–1415. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Young G, Young AG and Lakkis C: Review of
complications associated with contact lenses from unregulated
sources of supply. Eye Contact Lens. 40:58–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lorenzo-Morales J, Khan NA and Walochnik
J: An update on Acanthamoeba keratitis: Diagnosis, pathogenesis and
treatment. Parasite. 22:102015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Makdoumi K, Mortensen J, Sorkhabi O,
Malmvall BE and Crafoord S: UVA-riboflavin photochemical therapy of
bacterial keratitis: A pilot study. Graefes Arch Clin Exp
Ophthalmol. 250:95–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Stachon T, Wang J, Eppig T, Langenbucher
A, Bischoff M, Seitz B and Szentmáry N: KGF, FGFb, VEGF, HGF and
TGFβ1 secretion of human keratocytes following photodynamic
inactivation (PDI) in vitro. Graefes Arch Clin Exp Ophthalmol.
251:1987–1993. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Stachon T, Wang J, Song X, Langenbucher A,
Seitz B and Szentmáry N: Impact of
crosslinking/riboflavin-UVA-photodynamic inactivation on viability,
apoptosis and activation of human keratocytes in vitro. J Biomed
Res. 29:321–325. 2015.PubMed/NCBI
|
8
|
Wu MF, Stachon T, Wang J, Song X, Colanesi
S, Seitz B, Wagenpfeil S, Langenbucher A and Szentmáry N: Effect of
keratocyte supernatant on epithelial cell migration and
proliferation after corneal crosslinking (CXL). Curr Eye Res.
41:466–473. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Randleman JB, Khandelwal SS and Hafezi F:
Corneal cross-linking. Surv Ophthalmol. 60:509–523. 2015.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Papaioannou L, Miligkos M and
Papathanassiou M: Corneal collagen cross-linking for infectious
keratitis: A systematic review and meta-analysis. Cornea. 35:62–71.
2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang J, Stachon T, Eppig T, Langenbucher
A, Seitz B and Szentmáry N: Impact of photodynamic inactivation
(PDI) using the photosensitizer chlorin e6 on viability, apoptosis
and proliferation of human keratocytes in vitro. Graefes Arch Clin
Exp Ophthalmol. 251:2725–2731. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang J, Stachon T, Eppig T, Langenbucher
A, Seitz B and Szentmáry N: Impact of photodynamic inactivation
(PDI) using the photosensitizer chlorin e6 on viability, apoptosis,
and proliferation of human corneal endothelial cells. Graefes Arch
Clin Exp Ophthalmol. 251:1199–1204. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Rovaldi CR, Pievsky A, Sole NA, Friden PM,
Rothstein DM and Spacciapoli P: Photoactive porphyrin derivative
with broad-spectrum activity against oral pathogens In vitro.
Antimicrob Agents Chemother. 44:3364–3367. 2000. View Article : Google Scholar : PubMed/NCBI
|
14
|
Gad F, Zahra T, Francis KP, Hasan T and
Hamblin MR: Targeted photodynamic therapy of established
soft-tissue infections in mice. Photochem Photobiol Sci. 3:451–458.
2004. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Park JH, Moon YH, Bang IS, Kim YC, Kim SA,
Ahn SG and Yoon JH: Antimicrobial effect of photodynamic therapy
using a highly pure chlorin e6. Lasers Med Sci. 25:705–710. 2010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Martins SA, Combs JC, Noguera G, Camacho
W, Wittmann P, Walther R, Cano M, Dick J and Behrens A:
Antimicrobial efficacy of riboflavin/UVA combination in vitro for
bacterial and fungal isolates: A potential new treatment for
infectious keratitis. Invest Ophthalmol Vis Sci. 49:3402–3408.
2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Khan YA, Kashiwabuchi RT, Martins SA,
Castro-Combs JM, Kalyani S, Stanley P, Flikier D and Behrens A:
Riboflavin and ultraviolet light a therapy as an adjuvant treatment
for medically refractive Acanthamoeba keratitis: Report of 3 cases.
Ophthalmology. 118:324–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ekanayaka SA, McClellan SA, Barrett RP,
Kharotia S and Hazlett LD: Glycyrrhizin reduces HMGB1 and bacterial
load in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis
Sci. 57:5799–5809. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Girgis DO, Sloop GD, Reed JM and
O'Callaghan RJ: Susceptibility of aged mice to Staphylococcus
aureus keratitis. Curr Eye Res. 29:269–275. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
AnimalsGuide for the Care and Use of Laboratory Animals. 8th.
National Academies Press (US); Washington (DC): 2011, PubMed/NCBI
|
21
|
Pinto JG, Pereira AH, de Oliveira MA,
Kurachi C, Raniero LJ and Ferreira-Strixino J: Chlorin E6
phototoxicity in L. major and L. braziliensis promastigotes-in
vitro study. Photodiagnosis Photodyn Ther. 15:19–24. 2016.(In
Press). View Article : Google Scholar : PubMed/NCBI
|
22
|
Marquart ME: Animal models of bacterial
keratitis. J Biomed Biotechnol. 2011:6806422011. View Article : Google Scholar : PubMed/NCBI
|